Mount Sinai researchers have found an important clue to a rare but serious aftereffect of COVID-19 in children, known as multisystem inflammatory syndrome in children or MIS-C. The researchers reported that RNA sequencing of blood samples from the Mount Sinai ...

The goal of this study is to reveal the hub genes and molecular mechanisms of the coronavirus disease 2019 (COVID-19) acute respiratory distress syndrome (ARDS) based on the genome-wide RNA...

Faculty members from the University of Tennessee Health Science Center have led the development of PubSeq, a global digital data repository of COVID-19 RNA sequences. PubSeq is open to all interested...

The establishment of nasal mucosal immunity against SARS-CoV-2 through a nasal vaccine could be the most efficient way to combat COVID-19...

In December 2019, a new coronavirus, SARS-CoV-2, which causes the respiratory illness that led to the COVID-19 pandemic, was reported. In the face of...

Tracking the spread of COVID-19 Viruses spread because they can rapidly copy their genetic material and produce more virus. Each virus—including SARS-CoV-2, the virus that causes COVID-19—has its own unique RNA genetic blueprint. This RNA signature alerts scientists to the presence of a specific disease. Part of the obstacle scientists have ...

A new study from researchers at the University of Alabama at Birmingham is shining a light on the similarities and differences between COVID-19 and...

University of Missouri scientists receive $4 million grant from the National Institutes of Health to examine clues about the rate of infection in communities and virus variants...

The pandemic has shown that scientists across the globe are willing to join forces to better understand the virus and to develop new treatments and vaccines. Key scientific achievements in this respect – some of them already in the early ...

Rapid reporting at high throughput enables detection of potential vaccine escaping variant strains Zymo Research announced today their COVID-19 Variant Sequencing Service. This new global service expands Zymo Research’s end-to-end SARS-CoV-2 solutions that include sample collection, RNA extraction, and SARS-CoV-2 detection. Detecting ...